Enterprise Financial Services Corp (EFSC)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30	Closed	-$4K	–	1287
2021 Q2	$4K	Buy	30 +17	+131%	+$1.92K	﹤0.01%	1012
2021 Q1	$1K	Hold	13	–	–	﹤0.01%	1341
2020 Q4	$2K	Hold	13	–	–	﹤0.01%	1143
2020 Q3	$1K	Buy	+13	New	+$1.62K	﹤0.01%	1240

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s RETA Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2021, closing a stake of 30 shares — an estimated $4K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in RETA in Q3 2020 and held it in 4 quarters. The position peaked at $4K in Q2 2021. 181 funds tracked by Wall St. Rank hold RETA as of Q3 2021.

Enterprise Financial Services Corp (EFSC) reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 30 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2021, an estimated $4K.
Enterprise Financial Services Corp (EFSC) first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2020 and held it in 4 quarters.
Enterprise Financial Services Corp (EFSC)'s Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $4K in Q2 2021.
181 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.